The influence of photo-catalytic conversion on the pharmacodynamic properties of ergot alkaloids. Adrenolytic effect and toxicity of lumiergotamine (1) and lumiergocristine (1).
D018674:Adrenergic Antagonists; D002317:Cardiovascular Agents; D004876:Ergot Alkaloids / Q000494:pharmacology*; D010120:Oxytocics
D018674:Adrenergic Antagonists; D002317:Cardiovascular Agents; D004876:Ergot Alkaloids; D010120:Oxytocics
ERGOT ALKALOIDS/pharmacology